ALLMedicine™ Dry Skin Center

Aug 10th, 2022 - Cetuximab (Cmab) plays an important role in the treatment for recurrent or metastatic head and neck cancer (R/M HNC). To date, however, no safety data on biweekly administration of cetuximab at a dose of 500 mg/m2 (biweekly Cmab) for Japanese HNC ...

Aug 9th, 2022 - Patients receiving palliative care are more prone to dermatological disease. The aim of our study was to determine the frequency of dermatological diseases and associated factors in patients receiving palliative care support. This prospective obse...

Jul 31st, 2022 - The Hermansky-Pudlak syndrome (HPS) is a genetically heterogeneous group of diseases characterized by oculocutaneous albinism, bleeding diathesis, and systemic complications. It is the most common genetic disorder in Puerto Rico. These patients ar...

Jul 27th, 2022 - History Diagnostic criteria for atopic dermatitis (AD) have been proposed by Hanifin and Rajka (1980) and largely adopted by the American Academy of Allergy, Asthma, and Immunology. [17] Appropriate cases must have at least 3 major characteristics...

Jul 27th, 2022 - Practice Essentials Atopic dermatitis (AD) is a chronic, pruritic inflammatory skin condition (see image below) that typically affects the face (cheeks), neck, arms, and legs but usually spares the groin and axillary regions. AD usually starts in ...

Jul 19th, 2015 - Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) such as gefitinib, erlotinib, and afatinib are standard-of-care for first-line treatment of EGFR-mutant advanced non-small cell lung cancer (NSCLC). These drugs have a prove...

Jul 1st, 2022 - This is a research study to find out if a drug called, osimertinib, is safe and effective in treating advanced Non-Small Cell Lung Cancer (NSCLC) by targeting the treatment of epidermal growth factor receptor (EGFR) mutation exon 18 G719X, exon 20...

Jun 24th, 2022 - This is a randomized, controlled, parallel design, open-label phase 2 clinical study to compare the efficacy of the two proactive treatment arms versus the reactive arm, for the prevention of atopic dermatitis in children at high risk of food alle...

May 20th, 2022 - Effectiveness A measure of the extent to which a specific intervention, procedure, regimen, or service when deployed in the field of routine circumstances, does it intended to do for a specific population. (Wojtezak, 2002) In this study, effective...

May 9th, 2022 - In current Dermatology practice, options for moderate acne vulgaris remain limited. Moderate acne is clinically defined as acne that has not responded to at least three months of topical therapy and is not severe enough for initial treatment with ...

Apr 27th, 2022 - Double-blind placebo-controlled clinical trial to evaluate the effectiveness of a sterilized probiotic on skin health and hydration in adults with dry skin. The goal of the study is to determine if the addition of a skin-conditioning probiotic to ...

Aug 15th, 2022 - A growing bandwagon of TikTok influencers have been using and promoting calamine lotion as a makeup primer under foundation. Though this may seem to work as a base layer for some people, dermatologists have concerns about this trend, particularly ...

May 19th, 2022 - Microscopic evaluation of a dermoscopy-guided skin scraping revealed that this was a case of scabies. Classically, patients with scabies have many excoriated papules or plaques on their hands, genitals, and trunk with itching so intense that their.

Mar 3rd, 2022 - Atopic dermatitis (AD) is a chronic inflammatory skin disorder affecting 7% of adults and 13% of children in the United States. 1,2 Atopic dermatitis is characterized by pruritus, dry skin, and pain, all of which can negatively impact quality of li.

Jan 28th, 2022 - Patients with relapsed or corticosteroid-resistant immune thrombocytopenia (ITP) had a 33% higher response rate and 50% increase in sustained responses with all-trans retinoic acid (ATRA) plus low-dose rituximab (Rituxan), Chinese investigators re...

Jan 13th, 2022 - Adagrasib (MRTX849), both alone and in combination with cetuximab (Erbitux), demonstrated encouraging responses and disease control in heavily pretreated patients with KRAS G12C–mutated colorectal cancer (CRC), according to Jared Weiss, MD, who ad...